Aseptic Filling (PFS/Vials) for LAI – DQ Protocol

Document Control

Document Number: DQ-001

Version: 1.0

Effective Date: [Insert Date]

Prepared By: [Insert Name]

Reviewed By: [Insert Name]

Approved By: [Insert Name]

Design Qualification Protocol for Aseptic Filling Equipment in Long-Acting Injectables

Objective: To ensure that the Aseptic Filling equipment for Long-Acting Injectables meets all necessary design specifications and regulatory requirements.

Scope: This protocol applies to the Aseptic Filling equipment used for the aseptic filling of depot suspensions in production areas.

Responsibilities:

  • Validation Team: Responsible for executing and documenting the qualification activities.
  • Quality Assurance: Responsible for reviewing and approving the qualification documentation.
  • Production Team: Responsible for providing input on operational requirements and participating in testing.

Prerequisites:

  • Completion of User Requirement Specification (URS).
  • Installation Qualification (IQ) must be completed prior to this protocol.
  • Training of personnel on equipment operation and validation procedures.

Equipment Description:

The Aseptic Filling equipment is designed for the aseptic filling of Long-Acting Injectables (Depot Suspensions) into pre-filled syringes (PFS) and vials. The equipment includes features for maintaining sterility, ensuring accurate fill volumes, and providing a robust audit trail for compliance with regulatory standards.

Test ID Procedure Acceptance Criteria Evidence
T1 Verify fill accuracy by assessing fill volumes of PFS and vials. Fill volume must be within ± 5% of target volume. Fill volume measurement logs.
T2 Assess suspension homogeneity through visual inspection and sampling. No visible particulates; homogenous suspension. Visual inspection records and sample analysis reports.
T3 Validate aseptic controls by testing environmental monitoring data. All microbial counts must be below action limits as per Annex 1. Environmental monitoring reports.
T4 Review audit trail functionality of the filling equipment. Audit trail must be complete with no gaps or unauthorized changes. Audit trail logs.
See also  Control Strategy Meaning in Pharma: Definition, Elements & Examples

Detailed Test Cases:

Test Case T1: Verify fill accuracy.

  • Procedure: Collect samples from filled PFS and vials, measure fill volumes.
  • Acceptance Criteria: Fill volume must be within ± 5% of target volume.
  • Evidence: Documented measurement logs.

Test Case T2: Assess suspension homogeneity.

  • Procedure: Visually inspect and sample filled products for homogeneity.
  • Acceptance Criteria: No visible particulates; homogenous suspension.
  • Evidence: Inspection records and analysis reports.

Test Case T3: Validate aseptic controls.

  • Procedure: Review environmental monitoring data for the filling area.
  • Acceptance Criteria: All microbial counts must be below action limits as per Annex 1.
  • Evidence: Environmental monitoring reports.

Test Case T4: Review audit trail functionality.

  • Procedure: Examine audit trail logs for completeness and accuracy.
  • Acceptance Criteria: Audit trail must be complete with no gaps or unauthorized changes.
  • Evidence: Audit trail logs.

Deviations: Any deviations from the acceptance criteria must be documented and investigated. A formal deviation report should be generated and approved by Quality Assurance.

Approvals:

  • Prepared By: ______________________ Date: ___________
  • Reviewed By: ______________________ Date: ___________
  • Approved By: ______________________ Date: ___________